Next Article in Journal
Hexasodium Fytate (SNF472 or CSL525) Inhibits Ectopic Calcification in Various Pseudoxanthoma Elasticum and Calcinosis Cutis Animal Models
Next Article in Special Issue
Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
Previous Article in Journal
Oncoral Follow-Up for Outpatients Treated with Oral Anticancer Drugs Assessed by Relative Dose Intensity
Previous Article in Special Issue
Virtual Screening, Molecular Dynamics, and Mechanism Study of Homeodomain-Interacting Protein Kinase 2 Inhibitor in Renal Fibroblasts
 
 
Article

Article Versions Notes

Pharmaceuticals 2025, 18(4), 566; https://doi.org/10.3390/ph18040566
Action Date Notes Link
article pdf uploaded. 13 April 2025 11:48 CEST Version of Record https://www.mdpi.com/1424-8247/18/4/566/pdf-vor
article supplementary file uploaded. 13 April 2025 11:48 CEST - https://www.mdpi.com/1424-8247/18/4/566#supplementary
article xml file uploaded 15 April 2025 08:29 CEST Original file -
article xml uploaded. 15 April 2025 08:29 CEST Update -
article pdf uploaded. 15 April 2025 08:29 CEST Updated version of record https://www.mdpi.com/1424-8247/18/4/566/pdf-vor
article html file updated 15 April 2025 08:30 CEST Original file -
article xml file uploaded 15 April 2025 11:24 CEST Update -
article xml uploaded. 15 April 2025 11:24 CEST Update https://www.mdpi.com/1424-8247/18/4/566/xml
article pdf uploaded. 15 April 2025 11:24 CEST Updated version of record https://www.mdpi.com/1424-8247/18/4/566/pdf
article html file updated 15 April 2025 11:26 CEST Update https://www.mdpi.com/1424-8247/18/4/566/html
Back to TopTop